Mapping malaria risks
Prison needle programs could save millions in hepatitis C treatment costs
Prison needle programs could save double what they cost – our new modelling shows how
New treatment for drug-resistant tuberculosis commences in Papua New Guinea
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
"Quick, simple, and friendly": Understanding the acceptability and accessibility...
Antimicrobials for Neonates: Practitioner Decisions and Diagnostic Certainty.
Factors Associated with Timely First-Dose Pentavalent and Measles-Rubella Vaccin...
Agency in young people’s unsafe abortion trajectories in Papua New Guinea.
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Appeals
Monthly Giving
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
van Gemert C, Tapo PS, Sero K, Vanuatu Ministry of Health–Health Technical Advisory Group
Journal The Lancet. Infectious diseases
Published 08 Mar 2021
Volume 21
ISSUE 6
Pagination 769-770
DOI 10.1016/S1473-3099(21)00135-3